Association of Helicobacter pylori antibodies and severity of migraine attack

Behnaz Ansari1, Keivan Basiri1, Rokhsareh Meamar2

  • 1Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Abstract

Insights

Helicobacter pylori infection may be linked to migraine headaches. Eradicating this bacterium could potentially reduce migraine severity and frequency.

Area of Science:

  • Neurology
  • Gastroenterology
  • Infectious Diseases

Background:

  • Emerging research suggests a link between Helicobacter pylori infection and migraine headaches.
  • Helicobacter pylori (H. pylori) is a common bacterial infection.
  • Migraine is a prevalent neurological disorder characterized by severe headaches.

Purpose of the Study:

  • To investigate the association between H. pylori infection and migraine with aura (MA) and without aura (MO).
  • To evaluate the role of H. pylori infection in the pathogenesis of different migraine types.

Main Methods:

  • A case-control study involving 84 migraine patients (MA and MO) and 49 healthy controls.
  • Enzyme-linked immunosorbent assay (ELISA) was used to measure immunoglobulin G (IgG) and immunoglobulin M (IgM) antibody titers.
  • Headache severity was assessed using the Headache Impact Test (HIT-6) questionnaire.

Main Results:

  • Migraine patients showed significantly higher mean IgM antibody levels compared to controls (P = 0.004).
  • Headache Impact Test (HIT-6) scores were significantly higher in MA patients than MO patients (P < 0.001).
  • A significant correlation was observed between IgG antibody levels and HIT-6 scores in both MA (r = 0.407, P = 0.011) and MO (r = 0.499, P = 0.002) groups.

Conclusions:

  • The findings suggest a potential role of H. pylori infection in migraine headaches.
  • Treatment and eradication of H. pylori may offer a therapeutic strategy to alleviate migraine symptoms.
  • Further research is warranted to confirm the causal relationship and optimize treatment approaches.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.1K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
782
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
30
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.0K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.7K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.5K